- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01699919
A Study to Assess Analgesic Efficacy of Intravenous Lignocaine
Effect of Perioperative Systemic Lignocaine on Postoperative Pain in Patients Undergoing Elective Open Abdominal Surgeries- a Double Blinded Randomized Control Trial
The primary objectives of this study are to analyse the effect of perioperative systemic infusion of lignocaine on postoperative pain, postoperative nausea and vomiting and perioperative levels of inflammatory mediators in patients undergoing elective open abdominal surgeries.
The secondary parameters which will be observed during the study are the time to passage of flatus and stools postoperatively.
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Puducherry, India, 605006
- Jawaharlal Institute Of Postgraduate Medical Education And Research
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patients above 18 years of age
- undergoing elective open abdominal surgeries
- belonging to the American Society of Anaesthesiologists (ASA)status I,II,III
Exclusion Criteria:
- patients sensitive to lignocaine,
- patients suffering from cardiovascular diseases or with preoperative changes on electrocardiogram
- patients on beta blocker drugs
- patients on opioid drugs for prolonged period
- patients with functional bowel disorders
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: intravenous lignocaine
Intravenous lignocaine will be given as a bolus of 1.5mg/kg at the time of intubation followed by an infusion at a rate of 1.5mg/kg/hr throughout surgery and till one hour post surgery.
|
Intravenous lignocaine infusion is given in intraoperative period and till one hour post surgery.
Other Names:
|
|
Placebo Comparator: normal saline
Normal saline will be given as a bolus at the time of intubation and saline infusion given to patients in the control group during the surgery and till one hour post surgery.
|
Intravenous lignocaine infusion is given in intraoperative period and till one hour post surgery.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
postoperative pain scores using visual analogue scale
Time Frame: till 24 hours post surgery
|
Postoperative pain scores are assessed in the patients using a visual analogue scale in the first 24 hours post surgery
|
till 24 hours post surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of patient controlled analgesia demands
Time Frame: Till 24 hours post surgery
|
The total number of times the patient presses the demand button of PCA pump are noted.
|
Till 24 hours post surgery
|
|
Total amount of morphine consumed
Time Frame: till 24 hours post surgery
|
The total morphine consumption till 24 hours post surgery is noted.
|
till 24 hours post surgery
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Perioperative levels of inflammatory mediators
Time Frame: in preoperative period, immediate post op and 24 hours post surgery
|
Blood samples will be collected for the analysis of total leukocyte count, C-reactive protein and Interleukin-6 levels in the preoperative period, immediate postoperative and at 24 hours post surgery.
|
in preoperative period, immediate post op and 24 hours post surgery
|
|
time of passage of flatus and stools postoperatively
Time Frame: till postoperative day 7
|
Postoperative bowel function recovery will be assessed by noting the time of first passage of flatus and stools postoperatively
|
till postoperative day 7
|
Collaborators and Investigators
Investigators
- Principal Investigator: parnandi sridhar, MBBS, Junior resident,JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH, PUDUCHERRY, INDIA
Publications and helpful links
General Publications
- Groudine SB, Fisher HA, Kaufman RP Jr, Patel MK, Wilkins LJ, Mehta SA, Lumb PD. Intravenous lidocaine speeds the return of bowel function, decreases postoperative pain, and shortens hospital stay in patients undergoing radical retropubic prostatectomy. Anesth Analg. 1998 Feb;86(2):235-9. doi: 10.1097/00000539-199802000-00003.
- Cassuto J, Wallin G, Hogstrom S, Faxen A, Rimback G. Inhibition of postoperative pain by continuous low-dose intravenous infusion of lidocaine. Anesth Analg. 1985 Oct;64(10):971-4.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Postoperative Complications
- Pain
- Neurologic Manifestations
- Signs and Symptoms, Digestive
- Nausea
- Pain, Postoperative
- Vomiting
- Postoperative Nausea and Vomiting
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Membrane Transport Modulators
- Anesthetics, Local
- Voltage-Gated Sodium Channel Blockers
- Sodium Channel Blockers
- Lidocaine
Other Study ID Numbers
- IEC No. : EC/2011/2/24
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.